{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:06:27Z","timestamp":1790845587598,"version":"4.1.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02700","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T06:28:26Z","timestamp":1542695306000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract"],"prefix":"10.3389","volume":"9","author":[{"given":"Mirian","family":"Domenech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Yuste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1513\/AnnalsATS.201312-420PS","article-title":"Lung disease in a global context. A call for public health action","volume":"11","author":"Schluger","year":"2014","journal-title":"Ann Am Thorac Soc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0140-6736(06)69334-3","article-title":"Pneumonia: the leading killer of children","volume":"368","author":"Wardlaw","year":"2006","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the sustainable development goals","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12879-016-1648-2","article-title":"Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors","volume":"16","author":"Backhaus","year":"2016","journal-title":"BMC Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0140-6736(15)60733-4","article-title":"Community-acquired pneumonia","volume":"386","author":"Prina","year":"2015","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/clinids\/23.4.790","article-title":"Crisis in infectious diseases: time for a new paradigm?","volume":"23","author":"Casadevall","year":"1996","journal-title":"Clin Infect Dis."},{"key":"B9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinids\/21.1.150","article-title":"Return to the past: the case for antibody-based therapies in infectious diseases","volume":"21","author":"Casadevall","year":"1995","journal-title":"Clin Infect Dis."},{"key":"B10","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.38.8.1695","article-title":"Serum therapy revisited: animal models of infection and development of passive antibody therapy","volume":"38","author":"Casadevall","year":"1994","journal-title":"Antimicrob Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e00397","DOI":"10.1128\/mSphere.00397-17","article-title":"A new take on an old remedy: generating antibodies against multidrug-resistant gram-negative bacteria in a postantibiotic world","volume":"2","author":"Motley","year":"2017","journal-title":"mSphere"},{"key":"B12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nm.4465","article-title":"The role of vaccines in preventing bacterial antimicrobial resistance","volume":"24","author":"Jansen","year":"2018","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/14760584.2018.1525298","article-title":"Influenza vaccination and prevention of antimicrobial resistance","volume":"17","author":"Esposito","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1016\/S2214-109X(18)30043-3","article-title":"Vaccination to reduce antimicrobial resistance","volume":"6","author":"Atkins","year":"2018","journal-title":"Lancet Glob Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1016\/S1473-3099(17)30478-4","article-title":"Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance","volume":"18","author":"Atkins","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1176","DOI":"10.1016\/S2214-109X(17)30364-9","article-title":"Vaccination to reduce antimicrobial resistance","volume":"5","author":"Ginsburg","year":"2017","journal-title":"Lancet Glob Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e00428","DOI":"10.1128\/mBio.00428-16","article-title":"How can vaccines contribute to solving the antimicrobial resistance problem?","volume":"7","author":"Lipsitch","year":"2016","journal-title":"mBio"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1128\/JCM.01454-08","article-title":"Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007","volume":"47","author":"Fenoll","year":"2009","journal-title":"J Clinical Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1016\/j.vaccine.2015.08.009","article-title":"Secular trends (1990-2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-\/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination","volume":"33","author":"Fenoll","year":"2015","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/cid\/ciw067","article-title":"Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine","volume":"62","author":"Tomczyk","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.vaccine.2011.03.059","article-title":"Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance","volume":"29","author":"Giufre","year":"2011","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1003057","DOI":"10.1371\/journal.ppat.1003057","article-title":"Viral and bacterial interactions in the upper respiratory tract","volume":"9","author":"Bosch","year":"2013","journal-title":"PLoS Pathog."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1172\/JCI57762","article-title":"Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice","volume":"121","author":"Nakamura","year":"2011","journal-title":"J Clin Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/path.4638","article-title":"1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans","volume":"238","author":"Walters","year":"2016","journal-title":"J Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1128\/IAI.00155-09","article-title":"Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules","volume":"77","author":"Rameix-Welti","year":"2009","journal-title":"Infect Immun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1006770","DOI":"10.1371\/journal.ppat.1006770","article-title":"Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: a key role for mathematical modelling","volume":"14","author":"Opatowski","year":"2018","journal-title":"PLoS Pathog."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0137565","DOI":"10.1371\/journal.pone.0137565","article-title":"Emergence of amoxicillin-resistant variants of Spain9V-ST156 pneumococci expressing serotype 11A correlates with their ability to evade the host immune response","volume":"10","author":"Aguinagalde","year":"2015","journal-title":"PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1128\/CMR.13.4.615","article-title":"Interference of antibacterial agents with phagocyte functions: immunomodulation or \u201cimmuno-fairy tales\u201d?","volume":"13","author":"Labro","year":"2000","journal-title":"Clin Microbiol Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e12041","DOI":"10.1371\/journal.pone.0012041","article-title":"Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model","volume":"5","author":"Cafini","year":"2010","journal-title":"PLoS ONE"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e44135","DOI":"10.1371\/journal.pone.0044135","article-title":"Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains","volume":"7","author":"Ramos-Sevillano","year":"2012","journal-title":"PLoS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1128\/AAC.00427-08","article-title":"Effect of protein binding on the pharmacological activity of highly bound antibiotics","volume":"52","author":"Schmidt","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12248-008-9072-1","article-title":"Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing","volume":"11","author":"Beer","year":"2009","journal-title":"AAPS J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/jac\/dkq400","article-title":"Plasma protein binding may reduce antimicrobial activity by preventing intra-bacterial uptake of antibiotics, for example clindamycin","volume":"66","author":"Burian","year":"2011","journal-title":"J Antimicrob Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jac\/dkm078","article-title":"In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives","volume":"59","author":"Cafini","year":"2007","journal-title":"J Antimicrob Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/jac\/dkm115","article-title":"Effects of human albumin and serum on the in vitro bactericidal activity of cefditoren against penicillin-resistant Streptococcus pneumoniae","volume":"60","author":"Sevillano","year":"2007","journal-title":"J Antimicrob Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e2717","DOI":"10.1371\/journal.pone.0002717","article-title":"High protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulation","volume":"3","author":"Sevillano","year":"2008","journal-title":"PLoS ONE"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","author":"Collaborators","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1371\/journal.ppat.0030120","article-title":"Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae","volume":"3","author":"Yuste","year":"2007","journal-title":"PLoS Pathog."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1378\/chest.125.4.1335","article-title":"Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia","volume":"125","author":"Almirall","year":"2004","journal-title":"Chest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.4049\/jimmunol.166.11.6735","article-title":"Serum amyloid P component binds to Fc\u03b3 receptors and opsonizes particles for phagocytosis","volume":"166","author":"Bharadwaj","year":"2001","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.4049\/jimmunol.166.2.1200","article-title":"Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs","volume":"166","author":"Mold","year":"2001","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.4049\/jimmunol.178.11.7283","article-title":"C-reactive protein enhances immunity to Streptococcus pneumoniae by targeting uptake to Fc\u03b3R on dendritic cells","volume":"178","author":"Thomas-Rudolph","year":"2007","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1128\/AAC.48.11.4414-4421.2004","article-title":"Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals","volume":"48","author":"Gaziano","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"B47","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/infdis\/162.4.914","article-title":"Influence of subinhibitory concentrations of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa","volume":"162","author":"Darveau","year":"1990","journal-title":"J Infect Dis."},{"key":"B48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0002-9629(15)40337-4","article-title":"Complement component C9 enhances the capacity of beta-lactam antibiotics to kill Escherichia coli in vitro and in vivo","volume":"315","author":"Jung","year":"1998","journal-title":"Am J Med Sci"},{"key":"B49","first-page":"643","article-title":"Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway","volume":"54","author":"Verbrugh","year":"1985","journal-title":"Immunology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1099\/00222615-31-1-37","article-title":"The effect of antibiotics that inhibit cell-wall, protein, and DNA synthesis on the growth and morphology of Legionella pneumophila","volume":"31","author":"Rodgers","year":"1990","journal-title":"J Med Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1128\/AAC.49.4.1377-1380.2005","article-title":"Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane","volume":"49","author":"Imamura","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/jac\/dkr043","article-title":"Modulation of virulence gene expression by cell wall active antibiotics in Staphylococcus aureus","volume":"66","author":"Subrt","year":"2011","journal-title":"J Antimicrob Chemother."},{"key":"B53","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1128\/IAI.02811-14","article-title":"Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response","volume":"83","author":"Ramos-Sevillano","year":"2015","journal-title":"Infect Immun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.175.3.1813","article-title":"Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia","volume":"175","author":"Yuste","year":"2005","journal-title":"J Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1183\/09031936.06.00116805","article-title":"Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae","volume":"27","author":"Fukuda","year":"2006","journal-title":"Eur Resp J."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/jac\/dkm338","article-title":"Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro","volume":"60","author":"Anderson","year":"2007","journal-title":"J Antimicrob Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1128\/AAC.01459-06","article-title":"Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model","volume":"51","author":"Yasuda","year":"2007","journal-title":"Antimicrob Agents Chemother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fimmu.2018.00302","article-title":"The immunomodulatory effects of macrolides-A systematic review of the underlying mechanisms","volume":"9","author":"Zimmermann","year":"2018","journal-title":"Front Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(09)61114-4","article-title":"Pathogenesis, treatment, and prevention of pneumococcal pneumonia","volume":"374","author":"van der Poll","year":"2009","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1172\/JCI38322","article-title":"Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism","volume":"120","author":"McClelland","year":"2010","journal-title":"J Clin Invest."},{"key":"B62","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1128\/IAI.72.11.6191-6196.2004","article-title":"New concepts in antibody-mediated immunity","volume":"72","author":"Casadevall","year":"2004","journal-title":"Infect Immun."},{"key":"B63","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1128\/AAC.31.5.758","article-title":"Sub-MICs of cefuroxime and ciprofloxacin influence interaction of complement and immunoglobulins with Klebsiella pneumoniae","volume":"31","author":"Williams","year":"1987","journal-title":"Antimicrob Agents Chemother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"16969","DOI":"10.1073\/pnas.012669199","article-title":"The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice","volume":"99","author":"Brown","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1128\/IAI.00291-08","article-title":"Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway","volume":"76","author":"Yuste","year":"2008","journal-title":"Infect Immun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1128\/AAC.01470-12","article-title":"Macrolides and beta-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism","volume":"56","author":"Ramos-Sevillano","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1128\/AAC.46.5.1340-1344.2002","article-title":"Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model","volume":"46","author":"Casal","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1128\/AAC.46.12.4043-4044.2002","article-title":"Combined effect of specific antibodies (as serotherapy or preimmunization) and amoxicillin doses in treatment of Streptococcus pneumoniae sepsis in a mouse model","volume":"46","author":"Yuste","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2013full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect."},{"key":"B70","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/jac\/48.4.594","article-title":"Enhanced decrease of blood colony counts by specific anti-pneumococcal antibodies in the presence of sub-inhibitory concentrations of amoxicillin","volume":"48","author":"Yuste","year":"2001","journal-title":"J Antimicrob Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1128\/AAC.49.7.3095-3096.2005","article-title":"Specific antibodies, levofloxacin, and modulation of capsule-associated virulence in Streptococcus pneumoniae","volume":"49","author":"Tarrag\u00f3","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"B72","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev Anti Infect Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mib.2015.07.014","article-title":"Antibacterial monoclonal antibodies: the next generation?","volume":"27","author":"DiGiandomenico","year":"2015","journal-title":"Curr Opin Microbiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2471\/BLT.16.178061","article-title":"Therapeutic antibodies for infectious diseases","volume":"95","author":"Sparrow","year":"2017","journal-title":"Bull World Health Organ."},{"key":"B75","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1139\/w11-076","article-title":"Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump","volume":"57","author":"Al-Hamad","year":"2011","journal-title":"Can J Microbiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"262ra155","DOI":"10.1126\/scitranslmed.3009655","article-title":"A multifunctional bispecific antibody protects against Pseudomonas aeruginosa","volume":"6","author":"DiGiandomenico","year":"2014","journal-title":"Sci Transl Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s10096-011-1509-2","article-title":"PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice","volume":"31","author":"Song","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e73396","DOI":"10.1371\/journal.pone.0073396","article-title":"The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem","volume":"8","author":"Secher","year":"2013","journal-title":"PLoS ONE"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1128\/AAC.02190-13","article-title":"Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia","volume":"58","author":"Hua","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B80","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1128\/AAC.03918-14","article-title":"Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model","volume":"59","author":"Hilliard","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B81","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4161\/19420862.2014.985132","article-title":"Five birds, one stone: neutralization of alpha-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody","volume":"7","author":"Rouha","year":"2015","journal-title":"MAbs"},{"key":"B82","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/infdis\/jiu198","article-title":"Humanized staphylococcal enterotoxin B (SEB)-specific monoclonal antibodies protect from SEB intoxication and Staphylococcus aureus infections alone or as adjunctive therapy with vancomycin","volume":"210","author":"Varshney","year":"2014","journal-title":"J Infect Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1128\/AAC.04606-14","article-title":"Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax","volume":"59","author":"Migone","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1128\/AAC.04593-14","article-title":"Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax","volume":"59","author":"Biron","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B85","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02700\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T06:28:29Z","timestamp":1542695309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02700\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":85,"alternative-id":["10.3389\/fimmu.2018.02700"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02700","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"article-number":"2700"}}